Overview
Paul Armistead is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Armistead is rated as an Experienced provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant. Dr. Armistead is currently accepting new patients.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Peripheral T-Cell Lymphoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
6 Clinical Trials
University Of North Carolina At Chapel Hill
Anne Beaven is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Beaven is rated as a Distinguished provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Aspiration, and Bone Marrow Transplant.
Duke Blood Cancer Center
Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as a Distinguished provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.
Duke Blood Cancer Center
I care for patients who are diagnosed with lymphoma. I am really passionate about my work because our scientific understanding of lymphoma is rapidly increasing. This new knowledge is helping us care for our patients better. I strive to understand my patients, both how they feel physically and emotionally. I aim to guide my patients through the best treatment options for them. These choices may include new treatments and clinical trials. I always try to treat my patients like my own family. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Peripheral T-Cell Lymphoma. Her top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloblastic Leukemia without MaturationDr. Armistead isDistinguished. Learn about Acute Myeloblastic Leukemia without Maturation.
- Acute Myeloid Leukemia (AML)Dr. Armistead isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Bone Marrow TransplantDr. Armistead isDistinguished. Learn about Bone Marrow Transplant.
- Multiple MyelomaDr. Armistead isDistinguished. Learn about Multiple Myeloma.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Armistead isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Childhood Acute Myeloid LeukemiaDr. Armistead isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- LeukemiaDr. Armistead isAdvanced. Learn about Leukemia.
- Myelodysplastic Syndrome (MDS)Dr. Armistead isAdvanced. Learn about Myelodysplastic Syndrome (MDS).
- Experienced
- Acute Myelomonocytic LeukemiaDr. Armistead isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adult T-Cell LeukemiaDr. Armistead isExperienced. Learn about Adult T-Cell Leukemia.
- Aplastic AnemiaDr. Armistead isExperienced. Learn about Aplastic Anemia.
- Castleman DiseaseDr. Armistead isExperienced. Learn about Castleman Disease.
- Chronic B-Cell Leukemia (CBCL)Dr. Armistead isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Graft Versus Host Disease (cGvHD)Dr. Armistead isExperienced. Learn about Chronic Graft Versus Host Disease (cGvHD).